SlideShare a Scribd company logo
1 of 1
Eddie Halbisch
5529 Ashview Dr Apt C
Indianapolis, IN, 46237
Edward.Halbisch@gmail.com
608-220-3895
Work Experience...........................................................................................................
Lancaster / Sr. Chemist / Mar 2016 – Present
Project: Stability & re-evaluation (small & large molecule department)
 Perform analytical testing on stability samples per cGMP regulations
 Review and sign off on analyst data
Pharmaceutical Product Development / Scientist / Jan 2012 – Mar 2016
Project: Stability, development & feasibility (small molecule department)
 Sample & solution preparation in accordance with analytical methods
 Quantitatively analyze data
 Adhere to SOP and cGMP regulations and documentation
Key Strengths and Competencies..........................................................................
Laboratory Skills
Proficient in multiple laboratory instruments, including:
 HPLC (Waters & Agilent)  UPLC (Waters H-Class & Acquity)
 GC (Direct Inject & Headspace)  Capillary Electrophoresis
 Dissolution (Apparatus 1 & 2)  UV-Vis Spectrophotometer
Computer Skills
Proficient with multiple computer programs, including:
 Empower, Word, & Excel
Personal Skills
 Easily adaptable to changing work environments
 Quality assurance reviewer
 Designated trainer for new employees
Workplace Recognition
 Mentor of the year award (Jan 2014)
 Empower super user (Jan 2015)
References......................................
Megan Wincek
Group Leader with PPD
 612-220-1453
 Megan.Wincek@gmail.com
Casey Hoernemann
Group Leader with PPD, Mentor
 952-393-5415
 Casey.Hoernemann@gmail.com
Education................................................
University of Wisconsin
Oshkosh, Wisconsin
Bachelor of Science, Chemistry (2011)
Biomolecular Emphasis
Chemistry/Statistics tutor
2006-2008
Research lab assistant 2008-2009
EH

More Related Content

What's hot

Mgt 526 wk 3 apply signature assignment aligning operational needs with bus...
Mgt 526 wk 3   apply signature assignment aligning operational needs with bus...Mgt 526 wk 3   apply signature assignment aligning operational needs with bus...
Mgt 526 wk 3 apply signature assignment aligning operational needs with bus...NewUOPCourse
 
Asms qc Will Thompson Duke
Asms qc Will Thompson DukeAsms qc Will Thompson Duke
Asms qc Will Thompson DukeUC Davis
 
Hitting the Sweet Spot with Predictive Analytics (Michael Draugelis)
Hitting the Sweet Spot with Predictive Analytics (Michael Draugelis)Hitting the Sweet Spot with Predictive Analytics (Michael Draugelis)
Hitting the Sweet Spot with Predictive Analytics (Michael Draugelis)Ashleigh Kades
 
Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...
 Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu... Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...
Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...Obaid Ali / Roohi B. Obaid
 
Phinney varibility workshop
Phinney varibility workshopPhinney varibility workshop
Phinney varibility workshopUC Davis
 
Genpro Life Sciences
Genpro Life SciencesGenpro Life Sciences
Genpro Life SciencesAnoop Ambika
 
Devry acct 555 week 3 homework assignment
Devry acct 555 week 3 homework assignmentDevry acct 555 week 3 homework assignment
Devry acct 555 week 3 homework assignmentalbyalcot91
 
Mgt 526 wk 4 apply org chart
Mgt 526 wk 4   apply org chartMgt 526 wk 4   apply org chart
Mgt 526 wk 4 apply org chartNewUOPCourse
 

What's hot (13)

Mgt 526 wk 3 apply signature assignment aligning operational needs with bus...
Mgt 526 wk 3   apply signature assignment aligning operational needs with bus...Mgt 526 wk 3   apply signature assignment aligning operational needs with bus...
Mgt 526 wk 3 apply signature assignment aligning operational needs with bus...
 
Asms qc Will Thompson Duke
Asms qc Will Thompson DukeAsms qc Will Thompson Duke
Asms qc Will Thompson Duke
 
Hitting the Sweet Spot with Predictive Analytics (Michael Draugelis)
Hitting the Sweet Spot with Predictive Analytics (Michael Draugelis)Hitting the Sweet Spot with Predictive Analytics (Michael Draugelis)
Hitting the Sweet Spot with Predictive Analytics (Michael Draugelis)
 
PMED: APPM Workshop: Evidence-Based Practice v Practice-Based Evidence - Jaso...
PMED: APPM Workshop: Evidence-Based Practice v Practice-Based Evidence - Jaso...PMED: APPM Workshop: Evidence-Based Practice v Practice-Based Evidence - Jaso...
PMED: APPM Workshop: Evidence-Based Practice v Practice-Based Evidence - Jaso...
 
Top 22 Tips: Writing For FDA Compliance
Top 22 Tips: Writing For FDA ComplianceTop 22 Tips: Writing For FDA Compliance
Top 22 Tips: Writing For FDA Compliance
 
Abc bc training
Abc bc trainingAbc bc training
Abc bc training
 
ALT Approaches for Reliability
ALT Approaches for ReliabilityALT Approaches for Reliability
ALT Approaches for Reliability
 
Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...
 Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu... Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...
Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...
 
Environmental Testing
Environmental TestingEnvironmental Testing
Environmental Testing
 
Phinney varibility workshop
Phinney varibility workshopPhinney varibility workshop
Phinney varibility workshop
 
Genpro Life Sciences
Genpro Life SciencesGenpro Life Sciences
Genpro Life Sciences
 
Devry acct 555 week 3 homework assignment
Devry acct 555 week 3 homework assignmentDevry acct 555 week 3 homework assignment
Devry acct 555 week 3 homework assignment
 
Mgt 526 wk 4 apply org chart
Mgt 526 wk 4   apply org chartMgt 526 wk 4   apply org chart
Mgt 526 wk 4 apply org chart
 

Similar to Halbisch_Resume2

NIPTE Roadmap 2017 Discussion @ IFPAC 2017
NIPTE Roadmap 2017 Discussion @ IFPAC 2017NIPTE Roadmap 2017 Discussion @ IFPAC 2017
NIPTE Roadmap 2017 Discussion @ IFPAC 2017Ajaz Hussain
 
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...Medicines Discovery Catapult
 
Accelerating the production of safety summary and clinical safety reports - a...
Accelerating the production of safety summary and clinical safety reports - a...Accelerating the production of safety summary and clinical safety reports - a...
Accelerating the production of safety summary and clinical safety reports - a...Steffan Stringer
 
Need and Urgency for Harmonization and One Quality Voice
Need and Urgency for Harmonization and One Quality VoiceNeed and Urgency for Harmonization and One Quality Voice
Need and Urgency for Harmonization and One Quality VoiceAjaz Hussain
 
The Fast Track to Fair Lab Data
The Fast Track to Fair Lab Data The Fast Track to Fair Lab Data
The Fast Track to Fair Lab Data OSTHUS
 
Detailed Professional Resume for Chris Harding: Chemical Engineer/Biological ...
Detailed Professional Resume for Chris Harding: Chemical Engineer/Biological ...Detailed Professional Resume for Chris Harding: Chemical Engineer/Biological ...
Detailed Professional Resume for Chris Harding: Chemical Engineer/Biological ...typicalruin872
 
2013 OHSUG - Benefits of Out-of-the-Box-CDA for Siebel Clinical
2013 OHSUG - Benefits of Out-of-the-Box-CDA for Siebel Clinical2013 OHSUG - Benefits of Out-of-the-Box-CDA for Siebel Clinical
2013 OHSUG - Benefits of Out-of-the-Box-CDA for Siebel ClinicalPerficient
 
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 FinalNIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 FinalAjaz Hussain
 
Pharma statistic 2018
Pharma statistic 2018Pharma statistic 2018
Pharma statistic 2018Majdi Ayoub
 
Study Design to Support Reimbursement
Study Design to Support ReimbursementStudy Design to Support Reimbursement
Study Design to Support ReimbursementLyssa Friedman
 
Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10Lyssa Friedman
 
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016 Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016 Ajaz Hussain
 
Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...
Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...
Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...Praveen Chand
 
Information support for decision making. Christopher Hart 2012
Information support for decision making. Christopher Hart 2012Information support for decision making. Christopher Hart 2012
Information support for decision making. Christopher Hart 2012Christopher Hart
 
Preclinical development in the current Pharmaceutical space
Preclinical development in the current Pharmaceutical spacePreclinical development in the current Pharmaceutical space
Preclinical development in the current Pharmaceutical spaceIDBS
 
Introduction to Discovery Partnerships with Academia (DPAc)
Introduction to Discovery Partnerships with Academia (DPAc)Introduction to Discovery Partnerships with Academia (DPAc)
Introduction to Discovery Partnerships with Academia (DPAc)Andrew Pope
 

Similar to Halbisch_Resume2 (20)

NIPTE Roadmap 2017 Discussion @ IFPAC 2017
NIPTE Roadmap 2017 Discussion @ IFPAC 2017NIPTE Roadmap 2017 Discussion @ IFPAC 2017
NIPTE Roadmap 2017 Discussion @ IFPAC 2017
 
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
MDC Connect: In-Silico Drug Design - what to do, what not to do - project dri...
 
Accelerating the production of safety summary and clinical safety reports - a...
Accelerating the production of safety summary and clinical safety reports - a...Accelerating the production of safety summary and clinical safety reports - a...
Accelerating the production of safety summary and clinical safety reports - a...
 
Need and Urgency for Harmonization and One Quality Voice
Need and Urgency for Harmonization and One Quality VoiceNeed and Urgency for Harmonization and One Quality Voice
Need and Urgency for Harmonization and One Quality Voice
 
The Fast Track to Fair Lab Data
The Fast Track to Fair Lab Data The Fast Track to Fair Lab Data
The Fast Track to Fair Lab Data
 
Detailed Professional Resume for Chris Harding: Chemical Engineer/Biological ...
Detailed Professional Resume for Chris Harding: Chemical Engineer/Biological ...Detailed Professional Resume for Chris Harding: Chemical Engineer/Biological ...
Detailed Professional Resume for Chris Harding: Chemical Engineer/Biological ...
 
satish_kumar_Renewed
satish_kumar_Renewedsatish_kumar_Renewed
satish_kumar_Renewed
 
2013 OHSUG - Benefits of Out-of-the-Box-CDA for Siebel Clinical
2013 OHSUG - Benefits of Out-of-the-Box-CDA for Siebel Clinical2013 OHSUG - Benefits of Out-of-the-Box-CDA for Siebel Clinical
2013 OHSUG - Benefits of Out-of-the-Box-CDA for Siebel Clinical
 
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 FinalNIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
 
Pharma statistic 2018
Pharma statistic 2018Pharma statistic 2018
Pharma statistic 2018
 
Study Design to Support Reimbursement
Study Design to Support ReimbursementStudy Design to Support Reimbursement
Study Design to Support Reimbursement
 
Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10
 
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016 Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016
 
JJC Resume
JJC ResumeJJC Resume
JJC Resume
 
How to Write Research Proposal
How to Write Research ProposalHow to Write Research Proposal
How to Write Research Proposal
 
Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...
Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...
Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...
 
Information support for decision making. Christopher Hart 2012
Information support for decision making. Christopher Hart 2012Information support for decision making. Christopher Hart 2012
Information support for decision making. Christopher Hart 2012
 
Preclinical development in the current Pharmaceutical space
Preclinical development in the current Pharmaceutical spacePreclinical development in the current Pharmaceutical space
Preclinical development in the current Pharmaceutical space
 
resumeliliane
resumelilianeresumeliliane
resumeliliane
 
Introduction to Discovery Partnerships with Academia (DPAc)
Introduction to Discovery Partnerships with Academia (DPAc)Introduction to Discovery Partnerships with Academia (DPAc)
Introduction to Discovery Partnerships with Academia (DPAc)
 

Halbisch_Resume2

  • 1. Eddie Halbisch 5529 Ashview Dr Apt C Indianapolis, IN, 46237 Edward.Halbisch@gmail.com 608-220-3895 Work Experience........................................................................................................... Lancaster / Sr. Chemist / Mar 2016 – Present Project: Stability & re-evaluation (small & large molecule department)  Perform analytical testing on stability samples per cGMP regulations  Review and sign off on analyst data Pharmaceutical Product Development / Scientist / Jan 2012 – Mar 2016 Project: Stability, development & feasibility (small molecule department)  Sample & solution preparation in accordance with analytical methods  Quantitatively analyze data  Adhere to SOP and cGMP regulations and documentation Key Strengths and Competencies.......................................................................... Laboratory Skills Proficient in multiple laboratory instruments, including:  HPLC (Waters & Agilent)  UPLC (Waters H-Class & Acquity)  GC (Direct Inject & Headspace)  Capillary Electrophoresis  Dissolution (Apparatus 1 & 2)  UV-Vis Spectrophotometer Computer Skills Proficient with multiple computer programs, including:  Empower, Word, & Excel Personal Skills  Easily adaptable to changing work environments  Quality assurance reviewer  Designated trainer for new employees Workplace Recognition  Mentor of the year award (Jan 2014)  Empower super user (Jan 2015) References...................................... Megan Wincek Group Leader with PPD  612-220-1453  Megan.Wincek@gmail.com Casey Hoernemann Group Leader with PPD, Mentor  952-393-5415  Casey.Hoernemann@gmail.com Education................................................ University of Wisconsin Oshkosh, Wisconsin Bachelor of Science, Chemistry (2011) Biomolecular Emphasis Chemistry/Statistics tutor 2006-2008 Research lab assistant 2008-2009 EH